{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:15:42Z","timestamp":1788419742351,"version":"build-2803163510"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI138970, R21 AI140701, R21 AI164616, HHSN272201800043C"],"award-info":[{"award-number":["R01 AI138970, R21 AI140701, R21 AI164616, HHSN272201800043C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The development of effective vaccines against the opportunistic pathogen\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    (Pa) remains a critical public health priority for susceptible individuals due, in part, to the pathogen\u2019s intrinsic resistance mechanisms. This study evaluates the comparative immunogenicity and protective efficacy of two novel lipid A mimetic adjuvants, BECC438 (BECC438s or BECC438b) and BECC470 (BECC470s or BECC470b), in a subunit vaccine (L-PaF \u2013 a genetic fusion of Pa type III secretion system proteins PcrV and PopB with LTA1, the active moiety of heat-labile enterotoxin from enterotoxigenic\n                    <jats:italic>E. coli<\/jats:italic>\n                    ) formulated into an oil-in-water (o\/w) emulsion to target Pa. BECC438b and BECC470b are biologically derived lipid A analogues produced using a Bacterial Enzymatic Combinatorial Chemistry (BECC) platform. In contrast, BECC438s and BECC470s are chemically synthesized counterparts designed to achieve high purity, eliminating congener species that could interfere with selective Toll-like receptor 4 (TLR4) activation while minimizing potential reactogenicity. Vaccine formulations incorporating BECC438 or BECC470 with Pa antigens were administered to mice via intranasal (IN) or intramuscular (IM) routes, followed by assessment of immune responses and lung burden post-challenge with Pa. IN immunization with BECC438s or BECC438b induced robust antigen-specific IgG and IgA responses, with a balanced IgG1\/IgG3 profile that is indicative of mixed Th1\/Th2 polarization, however, IgG1 remained the predominant antibody subclass. BECC438s conferred the highest protection against Pa challenge by reducing bacterial burden and improving immune responses following IN immunization. Moreover, L-PaF\/ME\/BECC438s delivered IN provided superior protection when compared to IM immunization. Serum antibody titers and pre-challenged or post-challenged cytokine responses were directly correlated with bacterial clearance upon Pa pulmonary challenge. These findings suggest that BECC438 offers enhanced mucosal and systemic immunity over BECC470 in this infection model, making it a promising candidate for inclusion in mucosal next-generation Pa vaccines. Overall, this comparative analysis highlights the potential of BECC derived adjuvants to improve vaccine performance against multidrug-resistant pathogens like Pa following IN immunization. Further studies are warranted to evaluate their translational potential in human populations.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1908082","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:33Z","timestamp":1788417633000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative immunogenicity and protective efficacy of BECC438 and BECC470 adjuvants in a vaccine formulation against Pseudomonas aeruginosa"],"prefix":"10.3389","volume":"17","author":[{"given":"Prolay","family":"Halder","sequence":"first","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debaki Ranjan","family":"Howlader","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satabdi","family":"Biswas","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risha","family":"Haldar","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhrid","family":"Maiti","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Microbial Pathogenesis, University of Maryland","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackary K.","family":"Dietz","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Lu","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean K.","family":"Whittier","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[{"name":"Department of Microbial Pathogenesis, University of Maryland","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Picking","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"Picking","sequence":"additional","affiliation":[{"name":"Bond Life Sciences Center, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology & Integrative Biomedical Sciences, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4161\/hv.34296","article-title":"Vaccination against respiratory pseudomonas aeruginosa infection","volume":"11","author":"Grimwood","year":"2015","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2016.05.011","article-title":"Targeting the type three secretion system in pseudomonas aeruginosa","volume":"37","author":"Anantharajah","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"B3","article-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"ofac492.1671","DOI":"10.1093\/ofid\/ofac492.1671","article-title":"2049. National trends in infections caused by pseudomonas aeruginosa and carbapenem resistant pseudomonas aeruginosa, 2017 \u2013 2020","volume":"9","author":"Rose","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18986","article-title":"Current trends in the epidemiology of multidrug-resistant and beta-lactamase-producing pseudomonas aeruginosa in Asia and Africa: A systematic review and meta-analysis","volume":"13","author":"Salleh","year":"2025","journal-title":"PeerJ"},{"key":"B6","article-title":"Who bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00138-18","article-title":"Cystic fibrosis and pseudomonas aeruginosa: The host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulmonary Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: A long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000331224","article-title":"Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease","volume":"84","author":"Almagro","year":"2011","journal-title":"Respiration"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.15326\/jcopdf.2024.0582","article-title":"Clinical implications of pseudomonas aeruginosa colonization in chronic obstructive pulmonary disease patients","volume":"12","author":"Kwok","year":"2025","journal-title":"Chronic Obstr Pulm Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2018.233","article-title":"Progress toward the elusive pseudomonas aeruginosa vaccine","volume":"19","author":"Merakou","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1650999","article-title":"Immunological considerations in the development of pseudomonas aeruginosa vaccines","volume":"16","author":"Baker","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1227","article-title":"Enhanced annotations and features for comparing thousands of pseudomonas genomes in the pseudomonas genome database","volume":"44","author":"Winsor","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/iai.72.8.4741-4750.2004","article-title":"The v antigen of pseudomonas aeruginosa is required for assembly of the functional popb\/popd translocation pore in host cell membranes","volume":"72","author":"Goure","year":"2004","journal-title":"Infect Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583008","article-title":"Development of a broadly protective, self-adjuvanting subunit vaccine to prevent infections by pseudomonas aeruginosa","volume":"11","author":"Das","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00181-12","article-title":"The a subunit of escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes igg2a, iga, and th17 responses to vaccine antigens","volume":"80","author":"Norton","year":"2012","journal-title":"Infect Immun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1372349","article-title":"Development of a nano-emulsion based multivalent protein subunit vaccine against pseudomonas aeruginosa","volume":"15","author":"Howlader","year":"2024","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/cells9122617","article-title":"Understanding pseudomonas aeruginosa-host interactions: The ongoing quest for an efficacious vaccine","volume":"9","author":"Sainz-Mejias","year":"2020","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkag052","article-title":"Effectiveness and immunogenicity of a nanoemulsion protein subunit vaccine against pseudomonas aeruginosa: Investigation in diet-induced obese mice","author":"Biswas","year":"2026","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118326","article-title":"Respiratory mucosal vaccines: Applications, delivery strategies and design considerations","volume":"189","author":"Shi","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B23","doi-asserted-by":"publisher","first-page":"166.14","DOI":"10.4049\/jimmunol.204.supp.166.14","article-title":"Novel lipid a mimetics, becc438 and becc470, act as potent adjuvants in bacterial and viral subunit vaccines","volume":"204","author":"Harberts","year":"2020","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2025.06.03.657703","DOI":"10.1101\/2025.06.03.657703","article-title":"Enhancing protective efficacy and immunogenicity of hemagglutinin-based influenza vaccine utilizing adjuvants developed by becc","author":"Das","year":"2025","journal-title":"bioRxiv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid a-based tlr4 mimetic effectively adjuvants a yersinia pestis rf-v1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41598-023-27965-x","article-title":"Enhancing the protection of influenza virus vaccines with becc tlr4 adjuvant in aged mice","volume":"13","author":"Haupt","year":"2023","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18119","article-title":"Physicochemical characterization of biological and synthetic forms of two lipid a-based tlr4 agonists","volume":"9","author":"Hu","year":"2023","journal-title":"Heliyon"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00492-17","article-title":"Rationally designed tlr4 ligands for vaccine adjuvant discovery","volume":"8","author":"Gregg","year":"2017","journal-title":"mBio"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.085","article-title":"Novel tlr4 adjuvant elicits protection against homologous and heterologous influenza a infection","volume":"39","author":"Haupt","year":"2021","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.080","article-title":"Intranasal vlp-rbd vaccine adjuvanted with becc470 confers immunity against delta sars-cov-2 challenge in k18-hace2-mice","volume":"41","author":"Lee","year":"2023","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.706157","article-title":"Effect of two unique nanoparticle formulations on the efficacy of a broadly protective vaccine against pseudomonas aeruginosa","volume":"12","author":"Howlader","year":"2021","journal-title":"Front Pharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1046660","article-title":"Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants","volume":"11","author":"Iyer","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194912","article-title":"Impact of the tlr4 agonist becc438 on a novel vaccine formulation against shigella spp","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.06174-11","article-title":"Broadly protective shigella vaccine based on type iii secretion apparatus proteins","volume":"80","author":"Martinez-Becerra","year":"2012","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/iai.71.12.6915-6920.2003","article-title":"Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to streptococcus pneumoniae type 3","volume":"71","author":"Lefeber","year":"2003","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.890053","article-title":"Vaccines for pseudomonas aeruginosa: A long and winding road","volume":"13","author":"Priebe","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.12.3173-3179.1988","article-title":"Resistance of mucoid pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro","volume":"56","author":"Krieg","year":"1988","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.066","article-title":"Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease","author":"Granoff","year":"2009","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00203-22","article-title":"Multicomponent pseudomonas aeruginosa vaccines eliciting th17 cells and functional antibody responses confer enhanced protection against experimental acute pneumonia in mice","volume":"90","author":"Shaikh","year":"2022","journal-title":"Infect Immun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2022.05.002","article-title":"The unfulfilled potential of mucosal immunization","volume":"150","author":"Baker","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41541-025-01280-0","article-title":"Advances and prospects of respiratory mucosal vaccines: Mechanisms, technologies, and clinical applications","volume":"10","author":"Li","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41541-023-00618-w","article-title":"A protein subunit vaccine elicits a balanced immune response that protects against pseudomonas pulmonary infection","volume":"8","author":"Howlader","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/s41598-022-05157-3","article-title":"Vaccination of mice with hybrid protein containing exotoxin s and pcrv with adjuvants alum and mpl protects pseudomonas aeruginosa infections","volume":"12","author":"Asadi Karam","year":"2022","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/vaccines10071100","article-title":"Pseudomonas aeruginosa: Recent advances in vaccine development","volume":"10","author":"Killough","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1171213","article-title":"Functional assays to evaluate antibody-mediated responses against shigella: A review","volume":"13","author":"Boero","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"10.3791\/59400","DOI":"10.3791\/59400","article-title":"Opsonophagocytic killing assay to assess immunological responses against bacterial pathogens","author":"Paschall","year":"2019","journal-title":"J Vis Exp"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00617-18","article-title":"Development of an opsonophagocytic killing assay using hl-60 cells for detection of functional antibodies against streptococcus pyogenes","volume":"3","author":"Salehi","year":"2018","journal-title":"mSphere"},{"key":"B48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: Current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol BioMed"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17a-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"Tlr4 mediates vaccine-induced protective cellular immunity to bordetella pertussis: Role of il-17-producing t cells","volume":"177","author":"Higgins","year":"2006","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces Il-17-secreting T(Rm) cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mir0420-055r","article-title":"Roles of Il-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy","volume":"108","author":"Bendickova","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: Defining a role for Il-6","volume":"175","author":"Jones","year":"2005","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)00070-4","article-title":"Novel P19 protein engages Il-12p40 to form a cytokine, Il-23, with biological activities similar as well as distinct from Il-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117447","article-title":"Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-\u0393-treated macrophages to Pseudomonas aeruginosa infection","volume":"10","author":"Singh","year":"2015","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01160","article-title":"Il-22 plays a critical role in maintaining epithelial integrity during pulmonary infection","volume":"11","author":"Alcorn","year":"2020","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"11010","DOI":"10.1038\/s41598-017-11518-0","article-title":"Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model","volume":"7","author":"Broquet","year":"2017","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0182OC","article-title":"Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia","volume":"186","author":"Wu","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.7.4965","article-title":"Il-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa","volume":"181","author":"Priebe","year":"2008","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.601601","article-title":"Development of a chimeric vaccine against Pseudomonas aeruginosa based on the Th17-stimulating epitopes of Pcrv and Ampc","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1038\/s41598-020-63998-2","article-title":"Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal Iga and Th17 responses","volume":"10","author":"Raeven","year":"2020","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nm1710","article-title":"Il-22 mediates mucosal host defense against gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41522-025-00738-2","article-title":"Immune system dynamics in response to Pseudomonas aeruginosa biofilms","volume":"11","author":"Sahu","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18332\/pne\/170181","article-title":"Relationship between serum Tnf-A, Il-6, and Il- 10 levels and disease severity, and changes in the cytokines after treatment in patients with bacterial community-acquired pneumonia","volume":"36","author":"Dao","year":"2023","journal-title":"Pneumon"},{"key":"B66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cytogfr.2020.11.003","article-title":"Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics","volume":"59","author":"Dukhinova","year":"2021","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1908082\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:40:34Z","timestamp":1788417634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1908082\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2026.1908082"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1908082","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1908082"}}